Nephrocare Health Services Ltd

Analyst / Investor Meet - Intimation

Pursuant to Reg 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an investor conference call as per the disclosure annexed herewith.

Company Update / Analyst / Investor Meet View filing →

Shareholder Meeting / Postal Ballot-Scrutinizer's Report

Declartion of voting results along with scrutinizers report of the 17th AGM of the Company.

AGM/EGM / AGM View filing →

Analyst / Investor Meet - Outcome

In Continuation to our letter dated July 24, 2026 please find enclosed link of the audio recording of the Investors' Conference Call held on August 12, 2026 on the Unaudited Standalone ....

Company Update / Analyst / Investor Meet View filing →

Shareholder Meeting / Postal Ballot-Outcome of AGM

Summary of proceedings of the 17th AGM of the Company.

AGM/EGM / AGM View filing →

Board Meeting Outcome for Outcome Of Board Meeting Held On August 11, 2026.

Please find attached the outcome of Board meeting held on August 11, 2026.

Others / Outcome without intimation View filing →

Monitoring Agency Report

Pursuant to Reg 32 of SEBI Listing Regulations, read with Reg 41 of SEBI ICDR Regulations, please find enclosed herewith Monitoring Agency Report for quarter ended June 30, 2026.

Company Update / Monitoring Agency Report View filing →

Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of SEBI Listing Regulations, we hereby inform you that the Company has scheduled an Investor Conference Call as per the disclosure enclosed herewith.

Company Update / Analyst / Investor Meet View filing →

Trading Plan under SEBI (PIT) Regulations, 2015

Please find enclosed the Trading Plans dated August 05, 2026 received from Designated Persons of the company and same have been approved by the compliance officer.

Company Update / Trading Plan under SEBI (PIT) Regulations, 2015 View filing →

Board Meeting Intimation for The Company Has Informed BSE That The Meeting Of The Board Of Directors Is Scheduled On 11/08/2026 ,Inter Alia, To Consider And Approve The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026.

Nephrocare Health Services Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11-08-2026 ,inter alia, to consider and approve the Unaudited Standalone ....

Board Meeting / Board Meeting View filing →

Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an Investor Result Conference Call on Wednesday, 12th August, 2026 at 10:00 ....

Company Update / Analyst / Investor Meet View filing →

Newspaper Publication

Newspaper Publication regarding Notice on 17th Annual General Meeting and information on remote e-voting.

Company Update / Newspaper Publication View filing →

Newspaper Publication

Newspaper publication titled 17th Annual General Meeting of the Company through Video conferencing / Other Audio Visual Means, Cut-Off date information.

Company Update / Newspaper Publication View filing →

Reg. 34 (1) Annual Report.

Annual Report for the FY 2025-26 including Notice of the 17th Annual General Meeting of the Company.

Others / Reg. 34 (1) Annual Report View filing →

Notice Of 17Th Annual General Meeting Of The Company To Be Held On Wednesday, August 12, 2026.

Notice of 17th Annual General Meeting of the Company to be held on Wednesday, August 12, 2026.

AGM/EGM / AGM View filing →

Disclosure Under Regulation 36(1)(B) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations')

Dispatch of letter providing a web-link of the Annual Report for the FY 2025-26 along with AGM notice.

Company Update / General View filing →

Allotment of ESOP / ESPS

Pursuant to Reg 30 of SEBI Listing Regulations, 2015, we hereby inform that the Company has approved allotment of 2,18,297 equity shares of face value of Rs. 2/- each, pursuant to the exercise ....

Company Update / Allotment of ESOP / ESPS View filing →

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

We are enclosing herewith a certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 for quarter ended 30th June, 2026 received from M/s. KFIN Technologies Limited.

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

Issuance Of Standby Letter Of Credit Facilities

This is to inform that the company has provided collateral/security support by issuance of SBLC as per the details disclosed herewith.

Company Update / General View filing →

Issuance Of Corporate Guarantee And Standby Letter Of Credit Facilities

This is to inform that the Company has issued a Corporate Guarantee and provided collateral/security support as per the details annexed disclosed herewith.

Company Update / General View filing →

Disclosure Under Regulation 30 - Approval Of Nephroplus Employee Stock Option Scheme 2026.

Pursuant to Regulation 30 of SEBI LODR, 2015, we hereby inform you that the Company has approved the NephroPlus Employee Stock option scheme 2026 in the Board meeting held on June 22, 2026 ....

Company Update / General View filing →

Closure of Trading Window

Trading window shall be closed till 48 hours from the declaration of the Unaudited Financial Results of the Company for the quarter ended June 30, 2026.

Insider Trading / SAST / Closure of Trading Window View filing →

Cancellation Of Scheduled Analyst / Institutional Investor Meetings

In reference to our letter dated May 27, 2026, regarding Analyst Meet has now been cancelled due to unavoidable exigencies as per disclosure annexed herewith.

Company Update / General View filing →

Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an Investor Conference Call as per the disclosure enclosed herewith.

Company Update / Analyst / Investor Meet View filing →